These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30791135)

  • 1. Investigation of the relationship between macular pigment levels and rod-mediated dark adaptation in intermediate age-related macular degeneration.
    Beirne RO; McConnell E
    Clin Exp Optom; 2019 Nov; 102(6):611-616. PubMed ID: 30791135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rod-Mediated Dark Adaptation and Macular Pigment Optical Density in Older Adults with Normal Maculas.
    Zarubina AV; Huisingh CE; Clark ME; Sloan KR; McGwin G; Crosson JN; Curcio CA; Owsley C
    Curr Eye Res; 2018 Jul; 43(7):913-920. PubMed ID: 29634370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration.
    Owsley C; McGwin G; Clark ME; Jackson GR; Callahan MA; Kline LB; Witherspoon CD; Curcio CA
    Ophthalmology; 2016 Feb; 123(2):344-351. PubMed ID: 26522707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration.
    Ozawa Y; Shigeno Y; Nagai N; Suzuki M; Kurihara T; Minami S; Hirano E; Shinoda H; Kobayashi S; Tsubota K
    BMC Ophthalmol; 2017 Aug; 17(1):161. PubMed ID: 28851319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MACULAR PIGMENT OPTICAL DENSITY IS LOWER IN TYPE 2 DIABETES, COMPARED WITH TYPE 1 DIABETES AND NORMAL CONTROLS.
    Scanlon G; Connell P; Ratzlaff M; Foerg B; McCartney D; Murphy A; OʼConnor K; Loughman J
    Retina; 2015 Sep; 35(9):1808-16. PubMed ID: 25932554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health.
    Owsley C; Huisingh C; Jackson GR; Curcio CA; Szalai AJ; Dashti N; Clark M; Rookard K; McCrory MA; Wright TT; Callahan MA; Kline LB; Witherspoon CD; McGwin G
    Invest Ophthalmol Vis Sci; 2014 May; 55(8):4776-89. PubMed ID: 24854857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionally validated imaging endpoints in the Alabama study on early age-related macular degeneration 2 (ALSTAR2): design and methods.
    Curcio CA; McGwin G; Sadda SR; Hu Z; Clark ME; Sloan KR; Swain T; Crosson JN; Owsley C
    BMC Ophthalmol; 2020 May; 20(1):196. PubMed ID: 32429847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
    Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
    JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local Abundance of Macular Xanthophyll Pigment Is Associated with Rod- and Cone-Mediated Vision in Aging and Age-Related Macular Degeneration.
    Kar D; Clark ME; Swain TA; McGwin G; Crosson JN; Owsley C; Sloan KR; Curcio CA
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):46. PubMed ID: 32729911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.
    Sabour-Pickett S; Beatty S; Connolly E; Loughman J; Stack J; Howard A; Klein R; Klein BE; Meuer SM; Myers CE; Akuffo KO; Nolan JM
    Retina; 2014 Sep; 34(9):1757-66. PubMed ID: 24887490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the Classification of Age-Related Macular Degeneration Severity from the Northern Ireland Sensory Ageing Study Using a Measure of Dark Adaptation.
    Higgins BE; Montesano G; Crabb DP; Naskas TT; Graham KW; Chakravarthy U; Kee F; Wright DM; Hogg RE
    Ophthalmol Sci; 2022 Dec; 2(4):100204. PubMed ID: 36531574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Rod Function Phenotypes Across a Range of Age-Related Macular Degeneration Severities and Subretinal Drusenoid Deposits.
    Flynn OJ; Cukras CA; Jeffrey BG
    Invest Ophthalmol Vis Sci; 2018 May; 59(6):2411-2421. PubMed ID: 29847647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration.
    Jackson GR; Scott IU; Kim IK; Quillen DA; Iannaccone A; Edwards JG
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1427-31. PubMed ID: 24550363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration: Alabama Study on Early Age-related Macular Degeneration 2 Baseline.
    Owsley C; Swain TA; McGwin G; Clark ME; Kar D; Curcio CA
    Ophthalmol Sci; 2023 Jun; 3(2):100274. PubMed ID: 36875335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Changes Associated with Delayed Dark Adaptation in Age-Related Macular Degeneration.
    Laíns I; Miller JB; Park DH; Tsikata E; Davoudi S; Rahmani S; Pierce J; Silva R; Chen TC; Kim IK; Vavvas D; Miller JW; Husain D
    Ophthalmology; 2017 Sep; 124(9):1340-1352. PubMed ID: 28501377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability of Rod-Mediated Dark Adaptation Testing in Normal Aging and Early and Intermediate Age-Related Macular Degeneration.
    Owsley C; Swain TA; McGwin G; Bernard MM; Clark ME; Curcio CA
    Curr Eye Res; 2024 Jul; 49(7):725-730. PubMed ID: 38439539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between dark adaptation and macular pigment optical density in healthy subjects.
    Patryas L; Parry NR; Carden D; Aslam T; Murray IJ
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):657-63. PubMed ID: 24413682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relating Retinal Morphology and Function in Aging and Early to Intermediate Age-related Macular Degeneration Subjects.
    Sevilla MB; McGwin G; Lad EM; Clark M; Yuan EL; Farsiu S; Curcio CA; Owsley C; Toth CA
    Am J Ophthalmol; 2016 May; 165():65-77. PubMed ID: 26940163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
    Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.